Companyβ€’United Statesβ€’Updated May 4, 2026
Flare Capital Partners

Flare Capital Partners

Flare Capital Partners: Investor β€’ focus on Venture Capital β€’ active in North America, United States β€’ offices in United States β€’ AUM $1.0B.

Never miss breaking news

Get instant notifications when new news matching "Flare Capital Partners" are published.

Company Profile

Flare Capital Partners is a pioneering venture capital firm exclusively focused on transforming the healthcare industry through technology. The firm partners with exceptional founders who are leveraging software, data, and artificial intelligence to rebuild healthcare's operating system. Their investment strategy targets companies that aim to improve patient outcomes, broaden access to care, and reduce overall healthcare costs, with a particular emphasis on AI-powered efficiency and near-term return on investment.

Founded in 2013, Flare Capital Partners has established itself as a leader in healthtech investing. The firm manages approximately $1 billion in assets and has invested over $500 million in healthtech companies, resulting in 83 portfolio companies and 22 exits. They are known for their long-term, data-informed approach, seeking early signals of product-market fit and strong underlying economics in businesses that can scale within the unique constraints of the healthcare sector.

The firm's portfolio includes notable companies such as Aetion, Author Health, Elektra Health, SmarterDx, Greatly Health, Healink, and Qualified Health, among others. Flare Capital Partners actively supports its portfolio companies from Seed to Series B stages, with typical investments ranging from $5 million to $30 million and a target ownership of 10%–20%. They also foster the next generation of healthcare leaders through their Flare Scholars Program, which provides venture experience and mentorship to rising stars from leading graduate programs and healthcare institutions.

Flare Capital Partners boasts a team of seasoned investors, operators, clinicians, and technologists with deep expertise across multiple market cycles in healthcare. Key members include Co-Founder and General Partner Michael Greeley, along with partners Ian Chiang, Parth Desai, Dan Gebremedhin, Victor Lanio, and Margaret Malone. The firm further enhances its capabilities through an Industry Advisory Board of senior healthcare executives and an AI Advisory Council, connecting strategic partners and technology experts to accelerate AI-driven innovation in healthcare technology.

News & Signals (0)

No linked news activity found for this company.

Investor Listings

Similar Companies

Ranked by shared taxonomies: sector, subsector, geography, asset class and investor lists.

No similar companies found with overlapping taxonomy tags.